ReviewFrontiers in pharmacology2020

Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence.

Filippo Drago et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.